tiprankstipranks
Trending News
More News >
Alignment Healthcare, Inc. (ALHC)
NASDAQ:ALHC
US Market

Alignment Healthcare (ALHC) Earnings Dates, Call Summary & Reports

Compare
171 Followers

Earnings Data

Report Date
Apr 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
<0.01
Last Year’s EPS
-0.05
Same Quarter Last Year
Based on 8 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call communicated strong financial and operating progress: substantial membership and revenue growth, margin expansion, positive free cash flow, improved SG&A efficiency, market-quality achievements (100% 4+ star plans) and solid AEP momentum. Management acknowledged near-term headwinds from the final phase-in of V28, policy/rate uncertainty from CMS (advanced rate notice), and a higher first-year MBR driven by a heavier dual/LIS mix. Those risks were framed as manageable given the company’s clinically led model, technology platform and disciplined growth approach. Overall the positives (robust growth, profitability improvements, cash generation, and quality metrics) materially outweigh the moderate regulatory and mix-related lowlights.
Company Guidance
Alignment's initial 2026 guidance calls for year-end membership of 292,000–298,000, revenue of $5.14–5.19 billion (midpoint $5.16B, ~31% YoY growth), adjusted gross profit of $615–650 million (midpoint $633M, implied MBR ~87.7%), and adjusted EBITDA of $133–163 million (consistent with prior consensus near $145M); first‑quarter 2026 guidance is 281,000–285,000 members, $1.21–1.23 billion revenue, $138–148 million adjusted gross profit and $26–36 million adjusted EBITDA. Management noted the guide assumes H1 MBR modestly below the full‑year average and H2 slightly above, a flatter Part D slope, no assumption for sweep pickup (2025 sweep benefited adjusted gross profit/EBITDA by ≈$14M, ~30 bps to consolidated MBR), revenue PMPMs balanced by higher benchmarks and Part D direct subsidy offset by the final phase‑in of V28 and ex‑California mix, and continued SG&A leverage (2025 adjusted SG&A $385M, 9.7% of revenue) while building on 2025 results (FY 2025: 236,300 members, $3.9B revenue, $495M adjusted gross profit, MBR 87.5% (+130 bps), $110M adjusted EBITDA, 2.8% adj. EBITDA margin, $604M cash/investments).
Strong Membership and Revenue Growth
Q4 health plan membership of 236,300 (≈25% YoY growth). Full-year membership up 25% YoY. Q4 revenue of $1.0B (44% YoY growth) and full-year revenue of $3.9B (46% YoY growth).
Profitability and Margin Expansion
Full-year adjusted EBITDA of $110M vs roughly breakeven in 2024 (adjusted EBITDA margin 2.8%), representing ~270 basis points of margin expansion year-over-year. Q4 adjusted EBITDA of $11M, outperforming guidance (vs. guidance of negative $9M to negative $1M).
Improved Medical Benefit Ratio and Adjusted Gross Profit
Full-year adjusted gross profit $495M with a consolidated MBR of 87.5%, an improvement of 130 basis points YoY. Q4 adjusted gross profit $125M and adjusted MBR of 87.7%.
Operational Leverage and SG&A Efficiency
Full-year adjusted SG&A $385M (28% increase YoY in absolute dollars) but SG&A as a percent of revenue declined from 11.1% to 9.7% (≈140 basis points improvement), reflecting operating leverage as membership scaled.
Cash Flow and Balance Sheet Strength
Generated positive free cash flow in 2025 and ended the year with $604M in cash and investments. Closed a $200M revolving credit facility (not expected to be drawn), supporting capital structure maturation.
Successful AEP / Early 2026 Momentum
January 2026 membership grew to 275,300 (31% YoY). Broad growth across markets: 23% growth in California and >80% growth in ex-California counties. Nearly 20% improvement in AEP voluntary disenrollment and ~80% of gross sales sourced from plan switchers.
Replicable Quality Across Markets (Star Ratings)
100% of members and plans rated 4 stars or above. Notable plan ratings include a 5-star plan in North Carolina (3rd consecutive year), two 5-star plans in Nevada, a 4.5-star plan in Texas and a 4-star plan in Arizona, demonstrating quality portability outside California.
Technology & Care Model Advantages
Continued emphasis on AIVA/AVA data platform and Care Anywhere clinical model to improve visibility, cost control and scalability; targeted midyear deployments of AI use cases and workflow improvements expected to accelerate efficiency and scale.
Updated 2026 Guidance
2026 guidance: membership 292k–298k; revenue $5.14B–$5.19B (midpoint ≈31% YoY growth); adjusted gross profit $615M–$650M (midpoint MBR ≈87.7%); adjusted EBITDA $133M–$163M. Membership guidance midpoint raised by 2,000 since prior 8-K.
Recognition and Brand Momentum
Named to Fortune Magazine's World's Most Admired Companies list for the first time, reflecting external validation of the company's senior care focus.

Alignment Healthcare (ALHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ALHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 2026
2026 (Q1)
<0.01 / -
-0.05
Feb 26, 2026
2025 (Q4)
-0.15 / -0.05
-0.1668.75% (+0.11)
Oct 30, 2025
2025 (Q3)
-0.08 / 0.02
-0.14114.29% (+0.16)
Jul 30, 2025
2025 (Q2)
-0.07 / 0.07
-0.13153.85% (+0.20)
May 01, 2025
2025 (Q1)
-0.13 / -0.05
-0.2580.00% (+0.20)
Feb 27, 2025
2024 (Q4)
-0.19 / -0.16
-0.2536.00% (+0.09)
Oct 29, 2024
2024 (Q3)
-0.11 / -0.14
-0.1926.32% (+0.05)
Aug 01, 2024
2024 (Q2)
-0.12 / -0.13
-0.1513.33% (+0.02)
May 02, 2024
2024 (Q1)
-0.21 / -0.25
-0.2-25.00% (-0.05)
Feb 27, 2024
2023 (Q4)
-0.20 / -0.25
-0.3119.35% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ALHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
$20.42$19.22-5.88%
Oct 30, 2025
$17.12$16.86-1.52%
Jul 30, 2025
$13.00$13.78+6.00%
May 01, 2025
$16.77$15.53-7.39%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Alignment Healthcare, Inc. (ALHC) report earnings?
Alignment Healthcare, Inc. (ALHC) is schdueled to report earning on Apr 30, 2026, After Close (Confirmed).
    What is Alignment Healthcare, Inc. (ALHC) earnings time?
    Alignment Healthcare, Inc. (ALHC) earnings time is at Apr 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ALHC EPS forecast?
          ALHC EPS forecast for the fiscal quarter 2026 (Q1) is <0.01.